NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

AddLife AB (publ) (ST: ALIF-B)

 
ALIF-B Technical Analysis
5
As on 19th Jun 2025 ALIF-B STOCK Price closed @ 187.50 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 127.80 & Strong Buy for SHORT-TERM with Stoploss of 106.26 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ALIF-BSTOCK Price

Open 192.00 Change Price %
High 193.00 1 Day -5.50 -2.85
Low 187.50 1 Week -7.90 -4.04
Close 187.50 1 Month -4.90 -2.55
Volume 527086 1 Year 78.10 71.39
52 Week High 198.60 | 52 Week Low 94.85
 
ST Sweden Most Active Stocks
FING-B 0.01 0.00%
HDW-B 0.00 %
QLINEA 0.06 20.00%
WYLD 0.02 -33.33%
LIPI 0.22 -4.35%
QUIA 0.00 %
ENERS 0.00 %
LUNE 21.97 6.65%
SBB-B 6.32 -1.86%
NIBE-B 38.64 -0.85%
 
ST Sweden Top Gainers Stocks
KOPY 0.10 150.00%
SPIFF 0.04 33.33%
GBK 2.47 28.65%
RPLAN 1.28 28.00%
RO 0.65 22.64%
RO 0.65 22.64%
QLINEA 0.06 20.00%
ECC-B 0.58 18.37%
ICO 2.00 17.65%
STE-R 107.30 14.64%
 
ST Sweden Top Losers Stocks
SECI 0.01 -50.00%
SECI 0.01 -50.00%
ZICC 0.25 -34.21%
WYLD 0.02 -33.33%
AUR 0.82 -31.67%
AUR 0.82 -31.67%
ALLR 1.55 -26.54%
ASAP 0.03 -25.00%
ASAP 0.03 -25.00%
ASAP 0.03 -25.00%
 
 
ALIF-B
Daily Charts
ALIF-B
Intraday Charts
Whats New @
Bazaartrend
ALIF-B
Free Analysis
 
ALIF-B Important Levels Intraday
RESISTANCE198.10
RESISTANCE194.70
RESISTANCE192.60
RESISTANCE190.50
SUPPORT184.50
SUPPORT182.40
SUPPORT180.30
SUPPORT176.90
 
ALIF-B Forecast June 2025
4th UP Forecast233.27
3rd UP Forecast218.59
2nd UP Forecast209.52
1st UP Forecast200.44
1st DOWN Forecast174.56
2nd DOWN Forecast165.48
3rd DOWN Forecast156.41
4th DOWN Forecast141.73
 
ALIF-B Weekly Forecast
4th UP Forecast209.47
3rd UP Forecast202.42
2nd UP Forecast198.07
1st UP Forecast193.71
1st DOWN Forecast181.29
2nd DOWN Forecast176.93
3rd DOWN Forecast172.58
4th DOWN Forecast165.53
 
ALIF-B Forecast2025
4th UP Forecast390.89
3rd UP Forecast325.66
2nd UP Forecast285.34
1st UP Forecast245.02
1st DOWN Forecast129.98
2nd DOWN Forecast89.66
3rd DOWN Forecast49.34
4th DOWN Forecast-15.89
 
 
ALIF-B Other Details
Segment EQ
Market Capital 43292844032.00
Sector Healthcare
Industry Medical Instruments & Supplies
Offical website >
 
ALIF-B Address
ALIF-B
 
ALIF-B Latest News
 
Your Comments and Response on AddLife AB (publ)
 
ALIF-B Business Profile
AddLife AB (publ), together with its subsidiaries, supplies equipment, instruments, and reagents to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries in Sweden, Finland, Denmark, Norway, and internationally. The company operates through two segments, Labtech and Medtech. The Labtech segment provides analysis instruments, equipment, microscopes, consumables and reagents, as well as software support and technical services primarily to laboratories in medicine, research, academia, food, pharmaceutical, microbiology, clinical chemistry, coagulation, molecular biology, immunology, point-of-care testing, and veterinary diagnostics industries. This segment also offers training programs, seminars, and advisory services. The Medtech segment provides medical device products to surgery, thoracic medicine, neurology, wound care, anaesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare markets. AddLife AB (publ) was founded in 1906 and is headquartered in Stockholm, Sweden. Address: Brunkebergstorg 5, Stockholm, Sweden, 103 62
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service